Top pharmaceutical companies partnering with Celltrion, Ono Pharma, Sun Pharma, Syngene, Zydus, and Sichuan Kelun, according to the latest report from APAC Healthcare Weekly (March 16).

Here is a 400-word summary of the content: Asian Pharmaceutical’s Weekly Highlights: This week, several Asian pharmaceutical companies made significant announcements and developments, advancing their respective pipelines and solidifying their positions in the...

India now has access to a new treatment option for type 2 diabetes management as Glenmark Pharmaceuticals launches Empagliflozin, a medication designed to effectively control the disease.

Glenmark Pharmaceuticals has launched Empagliflozin, a widely recognized SGLT2 inhibitor, in India under the brand name Glempa. The company has introduced three treatment options: Glempa (Empagliflozin 10/25 mg), Glempa-L (Empagliflozin 10/25 mg + Linagliptin 5 mg),...